• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤甲素可减轻大鼠肺动脉高压和新生内膜形成。

Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats.

作者信息

Faul J L, Nishimura T, Berry G J, Benson G V, Pearl R G, Kao P N

机构信息

The Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305-5236, USA.

出版信息

Am J Respir Crit Care Med. 2000 Dec;162(6):2252-8. doi: 10.1164/ajrccm.162.6.2002018.

DOI:10.1164/ajrccm.162.6.2002018
PMID:11112148
Abstract

This paper reports the effect of triptolide (a diterpenoid triepoxide) on the development of monocrotaline (MCT)-induced pulmonary hypertension in pneumonectomized rats. Male Sprague- Dawley rats were injected with MCT (60 mg/kg) on Day 7 after left pneumonectomy. Rats received therapy from Day 5 to 35 with triptolide (0.25 mg/kg intraperitoneally, every other day, n = 10), or vehicle (0.1 ml of ethanol/cremophor intraperitoneally, every other day, n = 10). By Day 35, triptolide-treated rats demonstrated lower mean pulmonary arterial pressure (mPAP) than vehicle-treated rats (mPAP 21 +/- 3 versus 42 +/- 5 mm Hg, p < 0.001). Triptolide-treated rats also had significantly less right ventricular hypertrophy (RVH) and pulmonary arterial neointimal formation. In a rescue experiment, rats initiated therapy on Day 21. At Day 35, vehicle-treated rats (n = 4) had higher mPAP (40 +/- 9 mm Hg), greater RVH, and more severe pulmonary arterial neointimal formation than rats that received triptolide (0.25 mg/kg every other day, n = 7, mPAP 30 +/- 4 mm Hg) and rats that received triptolide (0.2 mg/kg daily, n = 7, mPAP 25 +/- 5 mm Hg, p < 0.01). In pneumonectomized rats that receive MCT, triptolide attenuates the development of pulmonary hypertension and RVH, and promotes regression of pulmonary arterial neointimal formation.

摘要

本文报道了雷公藤甲素(一种二萜类三环氧物)对肺切除大鼠中野百合碱(MCT)诱导的肺动脉高压发展的影响。雄性Sprague-Dawley大鼠在左肺切除术后第7天注射MCT(60mg/kg)。大鼠从第5天至第35天接受雷公藤甲素治疗(0.25mg/kg腹腔注射,隔天一次,n = 10)或溶剂对照(0.1ml乙醇/聚氧乙烯蓖麻油腹腔注射,隔天一次,n = 10)。到第35天,雷公藤甲素治疗的大鼠平均肺动脉压(mPAP)低于溶剂对照治疗的大鼠(mPAP 21±3对42±5mmHg,p<0.001)。雷公藤甲素治疗的大鼠右心室肥厚(RVH)和肺动脉内膜新生也明显较少。在一项挽救实验中,大鼠在第21天开始治疗。在第35天,溶剂对照治疗的大鼠(n = 4)比接受雷公藤甲素(0.25mg/kg隔天一次,n = 7,mPAP 30±4mmHg)和接受雷公藤甲素(0.2mg/kg每天一次,n = 7,mPAP 25±5mmHg,p<0.01)的大鼠具有更高的mPAP(40±9mmHg)、更严重的RVH和更严重的肺动脉内膜新生。在接受MCT的肺切除大鼠中,雷公藤甲素可减轻肺动脉高压和RVH的发展,并促进肺动脉内膜新生的消退。

相似文献

1
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats.雷公藤甲素可减轻大鼠肺动脉高压和新生内膜形成。
Am J Respir Crit Care Med. 2000 Dec;162(6):2252-8. doi: 10.1164/ajrccm.162.6.2002018.
2
[Effect of triptolide on the expression of matrix metalloproteinases 2 and 9 in lungs of experimental pulmonary hypertension].[雷公藤甲素对实验性肺动脉高压大鼠肺组织基质金属蛋白酶2和9表达的影响]
Zhongguo Dang Dai Er Ke Za Zhi. 2007 Oct;9(5):479-83.
3
[Effect of triptolide on the development of monocrotaline-induced pulmonary hypertension in pneumonectomized rat].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):806-9.
4
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats.40-O-(2-羟乙基)-雷帕霉素可减轻大鼠肺动脉高压和新生内膜形成。
Am J Respir Crit Care Med. 2001 Feb;163(2):498-502. doi: 10.1164/ajrccm.163.2.2006093.
5
Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats.大鼠新生内膜性血管闭塞和肺动脉高压发展过程的纵向转录分析
Physiol Genomics. 2004 Apr 13;17(2):150-6. doi: 10.1152/physiolgenomics.00198.2003.
6
Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.辛伐他汀可减轻大鼠平滑肌内膜增生和肺动脉高压。
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1403-8. doi: 10.1164/rccm.200203-268OC. Epub 2002 Aug 15.
7
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.肺血流动力学改变大鼠肺动脉对损伤的反应。肺动脉高压的新生内膜模型。
Am J Pathol. 1997 Oct;151(4):1019-25.
8
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.辛伐他汀通过诱导内膜平滑肌细胞凋亡,使大鼠免于致命性肺动脉高压。
Circulation. 2003 Sep 30;108(13):1640-5. doi: 10.1161/01.CIR.0000087592.47401.37. Epub 2003 Sep 8.
9
[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].瑞舒伐他汀对野百合碱诱导的大鼠肺动脉高压的影响
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Mar;39(3):247-53.
10
Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.骨髓来源细胞对与肺动脉高压和动脉内膜形成相关的血管重塑的多种贡献。
Circulation. 2007 Jan 30;115(4):509-17. doi: 10.1161/CIRCULATIONAHA.106.655837. Epub 2007 Jan 22.

引用本文的文献

1
Lymphatic malformations involving the thorax in children: a retrospective cohort study.儿童胸部淋巴管畸形:一项回顾性队列研究。
BMC Pulm Med. 2025 May 17;25(1):241. doi: 10.1186/s12890-025-03723-9.
2
Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.米内利德通过防止足细胞损伤显著减少阿霉素肾病小鼠的蛋白尿。
Appl Biochem Biotechnol. 2023 Dec;195(12):7379-7396. doi: 10.1007/s12010-023-04333-z. Epub 2023 Mar 31.
3
[Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].
[左肺切除联合颈静脉注射野百合碱吡咯诱导的肺动脉高压小鼠模型的肺血管重塑特征]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):821-827. doi: 10.12182/20220960508.
4
Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.用于治疗和预防肺动脉高压的传统草药医学发现
Front Pharmacol. 2021 Nov 9;12:720873. doi: 10.3389/fphar.2021.720873. eCollection 2021.
5
Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade.缓激肽 B1 受体阻断逆转肺动脉高压和新生内膜形成。
Respir Res. 2021 Oct 30;22(1):281. doi: 10.1186/s12931-021-01875-w.
6
Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition.血管紧张素转换酶2激活剂改善左肺切除联合血管内皮生长因子抑制大鼠模型中的重度肺动脉高压
Front Med (Lausanne). 2021 Feb 19;8:619133. doi: 10.3389/fmed.2021.619133. eCollection 2021.
7
Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review.雷公藤甲素在炎症性疾病治疗中的应用及机制——综述
Front Pharmacol. 2019 Dec 6;10:1469. doi: 10.3389/fphar.2019.01469. eCollection 2019.
8
Natural plant products in treatment of pulmonary arterial hypertension.天然植物产品在肺动脉高压治疗中的应用
Pulm Circ. 2018 Jul-Sep;8(3):2045894018784033. doi: 10.1177/2045894018784033. Epub 2018 Jun 5.
9
Triptolide reduces ischemia/reperfusion injury in rats and H9C2 cells via inhibition of NF‑κB, ROS and the ERK1/2 pathway.雷公藤红素通过抑制 NF-κB、ROS 和 ERK1/2 通路减少大鼠和 H9C2 细胞的缺血/再灌注损伤。
Int J Mol Med. 2018 Jun;41(6):3127-3136. doi: 10.3892/ijmm.2018.3537. Epub 2018 Mar 6.
10
Role of P2XR in the development and progression of pulmonary hypertension.P2XR在肺动脉高压发生发展中的作用。
Respir Res. 2017 Jun 24;18(1):127. doi: 10.1186/s12931-017-0603-0.